Posts by: admin

admin

Chris Comish serves as the Publisher of the website, and is responsible for directing the editorial focus as well as putting the finishing touches on many featured articles.

August 19, 2017

Lynparza’s New Tablet Formulation Receives FDA Approval For Ovarian Cancer

News

A new formulation of Lynparza (olaparib) tablets received FDA approval to prevent disease progression and relapse in ovarian cancer patients. The new tablets allow patients previously taking the drug in capsule ... Read more

July 25, 2016July 25, 2016

‘Liquid DNA Biopsy’ Helps to Spot Ovarian Cancer Patients at Risk of Relapse

News

Ovarian cancer relapses may be effectively monitored and, possibly, detected early by analyzing patients’ DNA in blood samples, Mayo Clinic researchers report in the study, “Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers,” published in the ... Read more